Importantly, it forms a protein complex with IGF2BP1, which binds to and stabilizes CEBPA mRNA levels through an m6A-dependent manner, enhancing CEBPA mediated PSPH/PSAT1 transcription and remodeling serine/glycine metabolism, and ultimately accelerates liver cancer growth and tumorigenicity. The gene discussed is PSPH; the disease is liver cancer.